Skip to main content
. 2020 Nov 27;38(1):721–738. doi: 10.1007/s12325-020-01561-1

Table 2.

Attrition of survey respondents

Original (and subsequent) number of respondents Number of respondents excluded at each stage, with reasons

4018

 →  2 (0.1%) were aged 0–19 years

4016

 →  1 (0.0%) was not a permanent resident of Japan

4015

 →  0 (0.0%) were not able to read and understand the Japanese language

4015

 →  206 (5.1%) had been diagnosed with type 1 diabetes or gestational diabetes

3809

 →  1103 (29.0%) did not take oral medications to control blood glucose level, or took a combination of oral and injectable medications

2706

 →  20 (0.7%) had been taking oral medications for only 0–5 months

2686

 →  424 (15.8%) had received injectable medications to control blood glucose level

2262

 →  1409 (62.3%) had a most recent measured HbA1c level below 7.0%, or did not know a measured HbA1c level from within the past year

853

 →  34 (4.0%) had health issues that made it difficult to participate in the survey

819

 →  11 (1.3%) worked for a pharmaceutical company, or were employed in a position where they directly treated patients with diabetes

808

 →  249 (30.8%) did not wish to participate in the survey

559

 →  38 (6.8%) incorrectly answered the test choice set

521

 →  21 (4.0%) selected treatment A in all choice sets, or treatment B in all choice sets
500 respondents (final analysis sample)

HbA1c glycated haemoglobin